CURA_1170x120_8-22-19

Medicaid drug reimbursement

Final AMP-based FULs coming soon

Final AMP-based FULs coming soon

The National Association of Chain Drug Stores reports that final average manufacturer price (AMP)-based federal upper limits (FULs) are set to be published by the Centers for Medicare & Medicaid Services (CMS) late this month. Once instituted, the final AMP-based FULs will “significantly change” Medicaid pharmacy reimbursement for branded and generic drugs, according to NACDS.